BIOCORTEX
BioCorteX is a pharmaceutical company specializing in enhanced therapeutics to cure neurodegenerative diseases using microorganisms.
BIOCORTEX
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.biocortex.co.uk
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Avrion Therapeutics
Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.
Current Employees Featured
Official Site Inspections
http://www.biocortex.co.uk Semrush global rank: 7.48 M Semrush visits lastest month: 477
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "BioCorteX"
Home | BioCorteX
BioCorteX takes a unique approach to therapeutics by considering three layers of interactions between drugs and bacteria: The direct effect of drug-bacteria metabolism, the indirect effect of bacteria on host physiology, and the local …See details»
BioCorteX Company Profile 2024: Valuation, Funding
BioCorteX was founded in 2021. Where is BioCorteX headquartered? BioCorteX is headquartered in London, United Kingdom. What is the size of BioCorteX? BioCorteX has 15 total employees. What industry is BioCorteX in? …See details»
About - BioCorteX
BioCorteX exists to change that. At BioCorteX, we have the most extensive and varied knowledge graph of microbiome samples in existence, consisting of millions of samples. These include …See details»
BIOCORTEX LTD overview - Find and update company information …
People for BIOCORTEX LTD (13287534) More for BIOCORTEX LTD (13287534) Registered office address 167-169 Great Portland Street, London, England, W1W 5PF . Company status …See details»
BIOCORTEX LTD Company Profile - Dun & Bradstreet
Biocortex ltd. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / london / …See details»
BioCorteX - LinkedIn
BioCortex needs massive storage resources; otherwise, the process will be slowed down or interrupted. This is where Google Cloud comes into play. The combination of world-leading …See details»
Biocortex Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Biocortex Ltd. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature.See details»
BioCorteX - Contacts, Employees, Board Members, Advisors
Organization. BioCorteX . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Number of Board Member and Advisor Profiles 2. …See details»
BioCorteX - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 28, 2023: Seed Round - …See details»
Contact Us - BioCorteX
Get in touch Our locations U.K. BioCorteX Ltd15-19 Bloomsbury Way,London WC1A 2TH U.S. BioCortex Inc.228 Park Ave, SPMB 56890New York 10003-1502 Australia BioCorteX Py …See details»
BioCorteX - Products, Competitors, Financials, Employees, …
BioCorteX Unveils Critical Bacteria Interactions in ADC Cancer Treatment, Enabled by Google Cloud. Oct 9, 2024. News provided by Share this article Share toX LONDON, Oct. 9, 2024 …See details»
BioCorteX Company Profile - Office Locations, Competitors ... - Craft
BioCorteX is a biotechnology company that provides therapeutics by leveraging the synergy between bacteria and medications. It develops CarbonMirror, which utilizes tech and artificial …See details»
BioCorteX Company Information - Funding, Investors, and More
The company BioCorteX has raised a total of $5m in funding over 1 rounds. Key Insights: Seed: $5m; 2024. BioCorteX Seed (2023, $5M) $5m. Discover BioCorteX. Company size. 1 - 11. …See details»
BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners …
BioCorteX, Tuesday, March 28, 2023, Press release picture "The interaction between the microbiome and its host is complex and remains a challenging question that requires an …See details»
BioCorteX raises $5 million in funding led by Sofinnova Partners …
Mar 28, 2023 “BioCorteX’s key differentiation lies in its unique team, which combines leading clinicians, engineers and microbiome scientists to develop entirely novel in-silico simulations, …See details»
BioCorteX raises $5 million to unlock drug-bacteria interactions
Mar 31, 2023 London-based bio-tech BioCorteX has raised $5 million in Seed funding. The funds will be used to further develop the company's Carbon Mirror platform which is a …See details»
Top BioCorteX Competitors and Alternatives | Craft.co
BioCorteX's main competitors include Broad Institute, Accutest, Molinos and The Jackson Laboratory. Compare BioCorteX to its competitors by revenue, employee growth and other …See details»
Research - BioCorteX
Jul 16, 2024 BioCorteX announces collaboration with Tempus to unlock the role of the bacteria in the tumour microenvironment (TME) creating personalised patient profiles. 19 August 2024 …See details»
BioCorteX Unveils Critical Bacteria Interactions in ADC Cancer ...
Oct 9, 2024 [London, United Kingdom] – [9th of October] – BioCorteX, a leading biotech innovator, today formally announced a breakthrough in the field of Antibody-Drug Conjugates …See details»